Exos TFP Holdings’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-63
Closed -$1.29M 480
2022
Q4
$1.29M Buy
+63
New +$1.28M 0.36% 84

Other funds holding CERO

Exos TFP Holdings's CERO Position: Q1 2023 in Review

Exos TFP Holdings sold out of CERo Therapeutics (CERO) in Q1 2023, closing a stake of 63 shares — an estimated $1.29M sold.

Exos TFP Holdings first reported a position in CERO in Q4 2022 and held it in 1 quarter. The position peaked at $1.29M in Q4 2022. 15 funds tracked by Wall St. Rank hold CERO as of Q1 2023.

  • Exos TFP Holdings reported no remaining CERo Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 63 CERo Therapeutics shares in Q1 2023, an estimated $1.29M.
  • Exos TFP Holdings first reported a position in CERo Therapeutics in Q4 2022 and held it in 1 quarter.
  • Exos TFP Holdings's CERo Therapeutics position peaked at $1.29M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.